EX-FILING FEES 4 sunshine-ex107.htm CALCULATION OF FILING FEE TABLES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Sunshine Biopharma Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Share

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees previously paid

Equity

Common Stock, par value $0.001 per share

457

(o)

(1)

(1)

–

–

–

Equity

Preferred Stock, par value $0.10 per share

457

(o)

(1)

(1)

–

–

–

Other

Warrants

457

(o)

(1)

(1)

–

–

–

Other

Rights

457

(o)

(1)

(1)

–

–

–

Other

Units

457

(o)

(1)

(1)

–

–

–

Unallocated (Universal) Shelf

–

457

(o)

$

100,000,000

–

$

100,000,000

(2)

$

0.00015310

$

15,310

Total Offering Amounts

$

100,000,000

$

0.00015310

$

15,310

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

$

15,310

(1)

An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered on a primary basis at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional securities of the registrant that become issuable by reason of any splits, dividends or similar transactions or anti-dilution adjustments.

(2)

Estimated solely for the purpose of calculating the registration fee. Subject to Rule 462(b) under the Securities Act, the aggregate initial offering price of all securities issued by the registrant pursuant to this registration statement will not exceed $100,000,000.